News Search Results
Apr 09, 2026, 08:15 ET Mimulus and GenScript Partner to Scale the World's First Zero-Watt Molecular Archive Infrastructure for the AI Era
Archive Technology™ and zero-watt Glacier Data Storage Cards, Mimulus combines the scaling laws of the semiconductor industry with the density of synthetic biology to solve the global archival storage crisis and liberate critical grid power for AI compute. Mimulus is making the future molecular. For more
More news about: Mimulus Corp
Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
physically permanent archival infrastructure for the age of AI. By combining the scaling laws of the semiconductor industry with the density of synthetic biology, Mimulus solves the global archival storage crisis and liberates critical grid power for AI compute. Led by a team of serial entrepreneurs with
More news about: GenScript Biotech Corporation
Apr 09, 2026, 08:00 ET GenScript and Mimulus Partner to Industrialize DNA-Based Data Storage for the AI Era
physically permanent archival infrastructure for the age of AI. By combining the scaling laws of the semiconductor industry with the density of synthetic biology, Mimulus solves the global archival storage crisis and liberates critical grid power for AI compute. Led by a team of serial entrepreneurs with
More news about: GenScript Biotech Corporation
Apr 09, 2026, 03:53 ET Synthetic Biology Market Analysis 2026-2031: Genome Engineering Accounts for 33.21% Share, with Asia-Pacific as the Fastest-Growing Region, Says Mordor Intelligence
https://www.mordorintelligence.com/industry-reports/synthetic-biology-market?utm_source=prnewswireSynthetic Biology Market Competitive OutlookThe synthetic biology market features a mix of biotechnology companies, research
More news about: Mordor Intelligence Private Limited
Apr 07, 2026, 15:43 ET LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market
Biotechnologies is a U.S.-based biomanufacturer redefining how the world produces specialty chemicals and ingredients. Through precision fermentation and synthetic biology, DMC creates sustainable, bio-based alternatives that reduce carbon emissions, enhance quality, and improve global supply chain resilience. The
More news about: LBB Specialties LLC
Apr 07, 2026, 15:16 ET LBB Specialties and DMC Biotechnologies Partner to Bring Fermented Inositols to the U.S. Market
Biotechnologies is a U.S.-based biomanufacturer redefining how the world produces specialty chemicals and ingredients. Through precision fermentation and synthetic biology, DMC creates sustainable, bio-based alternatives that reduce carbon emissions, enhance quality, and improve global supply chain resilience. The
More news about: LBB Specialties LLC
Apr 02, 2026, 12:00 ET Andrew Maynard, Renowned Futurist, AI Expert, and Director of ASU Future of Being Human Initiative, to Join Ellucian Live 2026 Mainstage
governance, he has become a leading voice helping institutions and society navigate the promises and risks of transformative technologies — from AI and synthetic biology to nanotechnology.As artificial intelligence rapidly evolves from emerging trend to embedded reality, leaders across higher education are
More news about: Ellucian
Apr 01, 2026, 15:59 ET Synthego Welcomes Supreme Court Order Finalizing Invalidation of Agilent CRISPR Patents
CRISPR-enabled research and therapeutics can flourish.About SynthegoSynthego is a pioneering biotechnology company specializing in synthetic biology and genome engineering. Dedicated to providing scientists with the tools, expertise, and support needed to accelerate scientific discovery, Synthego's
More news about: Synthego
Mar 31, 2026, 09:07 ET 2026 CANADA GAIRDNER AWARDS RECOGNIZE WORLD-LEADING SCIENTISTS FOR BREAKTHROUGH DISCOVERIES ADVANCING HUMAN HEALTH
development of treatments that can target harmful bacteria while preserving beneficial microbes, and they are informing genome-editing technologies and synthetic biology applications. By mapping the strategies of both bacteria and phages, Dr. Maxwell's research is opening new paths for fighting infections, managing
More news about: Gairdner Foundation
Mar 24, 2026, 07:50 ET Partillion Bioscience Advances a New Era of Cell-Cell Interaction Mapping at the 2026 Cell-Cell Symposium
With more than 250 registrants, the Cell-Cell Symposium brought together leaders in immunology, spatial biology, synthetic biology, and computational biology from institutions including UCLA, Caltech, USC, MD Anderson, St. Jude, and Yale, alongside companies spanning flow
More news about: Partillion Bioscience
Mar 20, 2026, 04:51 ET Precision Fermentation Market to Reach USD 57.1 Billion by 2032, Driven by Sustainable Protein Innovation and Biotech Advancements, Reports MarkNtel Advisors
meats, and processed food products.Advancements in Synthetic Biology and Microbial EngineeringAnother key factor supporting market growth is the rapid advancement in synthetic biology, genetic engineering, and fermentation technologies. Companies are leveraging
More news about: MarkNtel Advisors
Mar 19, 2026, 09:00 ET CAS Announces 2026 CAS Future Leaders
Chosen from a competitive global applicant pool, the new cohort of early‑career scientists conducts research across areas such as cheminformatics, synthetic biology, and materials science.
More news about: CAS
Mar 19, 2026, 09:00 ET CAS Announces 2026 CAS Future Leaders
Chosen from a competitive global applicant pool, the new cohort of early‑career scientists conducts research across areas such as cheminformatics, synthetic biology, and materials science.
More news about: CAS
Mar 18, 2026, 09:00 ET Sumitomo Corporation do Brasil and Cemvita Partner to Integrate production of Bio-Methane and Bio-Oil, a precursor of SAF in Brazil
lives and the world," based on Sumitomo's business philosophy passed down for over 400 years.About Cemvita Cemvita uses synthetic biology to turn carbon waste into high-value sustainable oils and critical inputs for sectors like aviation, agriculture, personal care, and industrial
More news about: Sumitomo Corporation do Brasil S.A.
Mar 13, 2026, 08:30 ET Pinnacle Food Group Limited Successfully Concludes 2026 Investor Day, Highlighting its "Dual-Engine" Growth Strategy
outlined its strategy to act as an industry consolidator, actively pursuing non-organic growth by identifying and injecting high-quality, fragmented synthetic biology intellectual property (IP) assets into its platform.Jiulong You, Chief Executive Officer of Pinnacle Food Group Limited, commented:
More news about: Pinnacle Food Group Limited
Mar 12, 2026, 09:00 ET K18 LAUNCHES TRIPLEBRIGHT™ - THE NEXT GENERATION OF PURPLE SHAMPOO DELIVERING BLONDE LIKE NEW
salon-exclusive damage repair service that protects, strengthens, and preserves hair health through even extreme salon services.As the leader in synthetic biology for beauty, K18 sets itself apart by addressing hair health from the inside out, rather than relying on surface-level solutions. With over 20
More news about: K18 Biomimetic Hairscience
Mar 10, 2026, 10:13 ET Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements
Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at advancing the field of synthetic biology. This collaboration brings together the strengths of both companies to drive innovation, streamline product development, and expand market reach.
More news about: Beijing Tsingke Biotech Co., Ltd.
Mar 10, 2026, 10:13 ET Tsingke Biotech and iGeneTech Forge Strategic Partnership to Lead Synthetic Biology Advancements
Tsingke Biotech") and iGeneTech Bioscience Co., Ltd. ("iGeneTech") have announced a strategic partnership aimed at advancing the field of synthetic biology. This collaboration brings together the strengths of both companies to drive innovation, streamline product development, and expand market reach.
More news about: Beijing Tsingke Biotech Co., Ltd.
Mar 04, 2026, 06:30 ET CDI Labs' Dr Tyler Hulett Ph.D. joins global Cancer Grand Challenges team taking on the cancer avoidance challenge
take on 18 challenges.About CDI Laboratories, Inc.CDI Labs is a specialized lab services company powered by cutting-edge synthetic biology platforms enabling novel serum antibody discovery across the autoreactome and immuno-exposome. CDI Labs is best known for HuProt™ human proteome
More news about: CDI LABORATORIES, INC.
Mar 02, 2026, 08:00 ET Ginkgo Bioworks Launches Ginkgo Cloud Lab, Powered by Autonomous Lab Infrastructure
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Feb 26, 2026, 16:26 ET Ginkgo Bioworks Reports Fourth Quarter and Full Year 2025 Financial Results, Announces Focus on Autonomous Labs Offerings and Divestiture of its Non-Core Biosecurity Business
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks
Feb 24, 2026, 07:00 ET ERS Genomics launches new Early Access Express License
cell lines and animal models for drug screening, bioproduction of antibodies and therapeutic proteins, animal and agricultural biotechnology, synthetic biology, including production of enzymes, food ingredients, and bio-based chemicals.Current ERS licensees include GSK, Merck, Bayer, Thermo Fisher
More news about: ERS Genomics
Feb 20, 2026, 09:15 ET AI Takes Flight: Five Companies Advancing Defense and Aerospace Intelligence
environmental evaluation, with applications spanning cognitive and physiological monitoring, flexible electronics, additive smart materials, and synthetic biology. AeroVironment continues to expand its defense technology portfolio beyond its established Switchblade loitering munition and Puma unmanned
More news about: USA News Group
Feb 18, 2026, 08:23 ET BiomEdit Initiates Final Field Safety Trial for Non-Antibiotic Poultry Biologic, Advancing Toward USDA Conditional Licensure
performance."About BiomEditBiomEdit is an animal health biotechnology company leveraging the power of the microbiome and synthetic biology to develop next-generation solutions for livestock and pet health. Founded in 2022, BiomEdit is backed by leading investors including Anterra
More news about: BiomEdit
Feb 18, 2026, 08:00 ET Ginkgo Bioworks and Invaio Sciences Enter Collaboration to Develop Manufacturing Technology for Peptide-based Agricultural Products
business opportunities, including with respect to our solutions and tools offerings, (iv) the risk of downturns in demand for products using synthetic biology, (v) the uncertainty regarding the demand for passive monitoring programs and biosecurity services, (vi) changes to the biosecurity industry,
More news about: Ginkgo Bioworks